Who Owns BBC?

Virtus Biotech Clinical Trials ETF — Institutional Ownership & 13F Holdings

$43.80

+0.99 (+2.31%)

Market Cap

$38.4M

Shares Outstanding

799,954

Institutional Holders

10

Total Inst. Value

$954K

% of Float Held

QoQ Holder Change

-5

Institutional data as of Q1 2025

New Positions

4

Closed Positions

4

Increased

0

Decreased

2

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1JANE STREET GROUP, LLCNew$371K21,149
2LPL Financial LLC$209K11,914
3TORONTO DOMINION BANKNew$175K10,000
4MORGAN STANLEY$148K8,444
5US BANCORP \DE\$18K1,000
6GKV Capital Management Co., Inc.New$14K802
7Dynamic Wealth Strategies, LLCNew$14K802
8Federation des caisses Desjardins du Quebec$5K294
9Allworth Financial LP$18710
10NewEdge Advisors, LLC$885

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue
MORGAN STANLEY-3K$148K
LPL Financial LLC-1K$209K

Related Stocks

Frequently Asked Questions

How many institutional investors hold BBC?

As of Q1 2025, 10 institutional investors report holding BBC (Virtus Biotech Clinical Trials ETF) in their 13F filings.

Which hedge fund owns the most BBC?

The largest institutional holder of BBC is JANE STREET GROUP, LLC with $371K in shares.

Are institutions buying or selling BBC?

This quarter, 4 institutions opened new positions in BBC and 4 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.